Physician profile
Andreia Arnold
NPI 1558727255
$428.79
in general payments reported to CMS, 2019-2025
14 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $47.58 · 2022: $126 · 2023: $109 · 2024: $20.06 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $124.34 | 2022-2025 | Proclaim |
| Lilly USA, LLC | $40.13 | 2022-2023 | Mounjaro |
| Phadia US INC. | $37.78 | 2022 | |
| Abbvie INC. | $36.12 | 2021 | |
| Protega Pharmaceutials INC | $35.06 | 2023 | Roxybond |
| Xeris Pharmaceuticals, INC. | $21.82 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.29 | 2023 | |
| Impulse Dynamics (USA) INC. | $20.06 | 2024 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.00 | 2023 | Jardiance |
| Exact Sciences Corporation | $17.11 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $17.09 | 2023 | Ozempic, Rybelsus |
| Qiagen, LLC | $13.74 | 2022 | |
| Shield Therapeutics INC | $12.79 | 2022 | |
| Cranial Technologies, INC | $11.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andreia Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.